Dr. Bond’s research encompasses several areas, including hospital-acquired infections, the safety of new therapies, and rare medical conditions. For example, he investigates the effectiveness of antibiotic treatments in hospitalized patients and has found that urinary tract infections are the most common. He also studies novel treatments like siRNA therapeutics, which have shown low risks of immune responses. Moreover, his work includes examining specific diseases like ALS and Parkinson's, shedding light on potential new treatment options while also looking at the healthcare system's ability to support patient needs in varied conditions.
Key findings
In a study of over 8,000 hospitalized patients, urinary tract infections were the most prevalent, particularly among women, with survival rates for skin infections at 94.4% compared to 81.7% for blood infections.
In his analysis of siRNA therapies, only 6% of patients developed antibodies against the treatments, with no negative effects on their efficacy, suggesting efficient drug testing processes.
In research on Parkinson's disease, azathioprine treatment showed a slight improvement in movement issues (0.54 points) but was not statistically significant compared to a placebo.
The procalcitonin test usage in COVID-19 patients led to a reduction in early antibiotic prescribing by an average of 0.43 days and overall antibiotic use by 0.72 days without impacting patient health.
In studying RTT in Ontario, researchers identified 246 cases, with 85% of patients experiencing developmental disabilities and frequent healthcare service utilization.
Frequently asked questions
Does Dr. Bond study infections?
Yes, Dr. Bond examines various types of infections, particularly in hospitalized patients, to improve treatment outcomes.
What treatments has Dr. Bond researched?
He has researched innovative treatments including siRNA therapeutics and azathioprine for conditions like ALS and Parkinson's disease.
Is Dr. Bond's work relevant to COVID-19 patients?
Yes, his studies on antibiotic use during the COVID-19 pandemic highlight how testing can help reduce unnecessary treatments for patients.
How does Dr. Bond's research help patients with rare conditions?
His work on conditions like RTT helps in understanding the healthcare needs and challenges these patients face, aiming for improved healthcare management.
What can Dr. Bond's research tell us about drug safety?
His studies, particularly on siRNA therapies, indicate that many new treatments have a low risk of unwanted immune responses, which is crucial for patient safety.
Publications in plain English
Laser fenestration of the dorsal pharyngeal recess does not correct experimentally induced dorsal nasopharyngeal collapse in horses.
2026
Veterinary surgery : VS
Jeong S, Bond S, Bayly W, Sole-Guitart A
Plain English This study looked at how a surgical procedure called laser fenestration affects breathing problems in horses caused by a condition known as dorsal nasopharyngeal collapse (NPC). The researchers found that after inducing NPC, the horses' breathing abilities significantly decreased, with measures like maximum oxygen uptake dropping by over 63 mL/kg/min. However, the surgery did not improve breathing after NPC was induced, and only a slight improvement was noted in some cases.
Who this helps: This research primarily helps veterinarians and horse owners understand the limitations of this treatment for respiratory issues in horses.
Embedding healthy workplace culture into wellbeing curricula.
2026
Internal medicine journal
Martin JH, Bond S, Sabesan S
Plain English This study looked at the importance of workplace culture in improving the wellbeing of medical students and healthcare workers, as rising issues like burnout and staff shortages are becoming critical. Researchers found that traditional wellbeing programs too often focus only on individuals rather than the culture of the workplace itself, which is essential for supporting a healthy workforce. By developing training programs that include lessons on creating a positive workplace culture, we can better prepare future healthcare professionals to foster environments that promote mental health and safety at work.
Who this helps: This helps medical students, healthcare workers, and ultimately patients by improving the conditions of care.
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.
2026
The Lancet. Neurology
Greenland JC, Dresser K, Cutting E, Donegan R, Bond S +12 more
Plain English This study looked at whether the drug azathioprine could slow the progression of early Parkinson's disease. Researchers tested 66 patients over 12 months and found that those taking azathioprine showed a slightly larger improvement in movement issues—0.54 points on a scale compared to 0.13 points for those taking a placebo—but this result wasn't statistically significant. Although the drug was generally well tolerated, with similar side effects reported in both groups, it didn't significantly impact the main measure of disease progression, making it unclear if azathioprine could be helpful for patients with Parkinson's.
Who this helps: This research primarily benefits patients with early Parkinson's disease, especially women, who may experience different effects from the treatment.
Pilotto F, Toth TD, Bond S, Schmitz A, Diab R +7 more
Plain English This study focused on understanding how certain cell processes are disrupted in ALS, a severe disease that causes progressive muscle weakness. Researchers discovered that ALS-related mutations lead to problems in how cells release neurotransmitters and manage stress, contributing to the death of motor neurons. They tested a modified form of GM1, called Talineuren (TLN), and found it improved cell functions and reduced harmful protein buildup in mice, suggesting it could help slow down disease progression.
Who this helps: This research benefits ALS patients by potentially providing a new treatment option to slow disease advancement.
Prolonged wireless measurement of intragastric pH in foals.
2026
Journal of veterinary internal medicine
Hodgson E, Romano TR, Stewart A, Bond S, Wise J
Plain English This study investigated how to measure stomach acidity in young horses (foals) using a wireless capsule. Researchers found that the capsules successfully stayed attached to the foals' stomach lining for an average of 7 days in most cases, with a mean stomach pH of 3.0. As the foals grew older, their stomach acidity increased, which helps improve understanding of their digestive health.
Who this helps: This benefits veterinarians and researchers working to treat and understand gastric issues in foals.
The Calcium Connection: Explaining Motor Neuron Vulnerability in ALS.
2026
Cells
Dellazizzo Toth T, Bond S, Saxena S
Plain English Researchers studied how problems with calcium in nerve cells relate to the disease ALS, which causes muscle weakness and eventually death. They found that certain motor neurons, which are particularly affected by ALS, have too much calcium entering them and not enough calcium-binding proteins to help manage it, making them more vulnerable to damage. Understanding this calcium imbalance is crucial because it could lead to new treatments that might better protect these motor neurons and slow down the progression of ALS.
Who this helps: This helps patients with ALS and their doctors by pointing to new treatment targets.
Behavioral Thermoceptive Responses and Morphologic Correlates in Mouse Models of CMT1A, HNPP, and Aging.
2026
Journal of the peripheral nervous system : JPNS
Oberoi V, Campbell JO, Akpabli-Tsigbe N, Imran F, Bond S +8 more
Plain English This study looked at how mice with certain nerve conditions and aging respond to temperature changes, which is important for understanding sensory problems. Researchers found that older mice had trouble sensing heat and behaved differently around warmer areas, while mice with inherited nerve disorders like CMT1A and HNPP reacted more like healthy mice. These findings are crucial because they help explain why some people with nerve conditions or aging experience abnormal heat perception, which can help inform better treatments.
Who this helps: This helps patients with peripheral neuropathies and age-related nerve issues.
Shearwaters make efficient navigational decisions, even at very fine scales.
2026
The Journal of experimental biology
Lancaster-Reeves L, Bond S, Morford J, Siddiqi-Davies K, Wynn J +7 more
Plain English Researchers studied how Manx shearwaters, a type of seabird, navigate when they are near their colony. By moving these birds to different locations around the island, they found that the shearwaters consistently chose a shorter route to get around the island, even when the distance differences were small. This ability to make efficient navigation decisions is important because it shows how well these birds can learn and adapt their routes, which helps them save energy during long trips.
Who this helps: This research benefits ornithologists and conservation efforts aimed at protecting seabird habitats.
Reverse-Type Takotsubo Cardiomyopathy: A Case Report.
2026
Cureus
Tyre JA, Hampton SA, Bond S, Grubb K
Plain English This study looked at a rare heart condition called reverse Takotsubo cardiomyopathy, which usually affects younger men but was found in a 74-year-old woman after she experienced stress from a physical altercation. The woman exhibited chest pain and elevated cardiac markers, but tests showed no significant blockage in her heart arteries. Understanding reverse Takotsubo is important because, despite the initial severe symptoms, patients often recover quickly, helping doctors make better treatment decisions for similar cases.
Who this helps: This helps patients experiencing chest pain and doctors diagnosing heart conditions.
The Eye That Felt Alive: A Rare Case of Subconjunctival Loa loa Infection in the United Kingdom.
2026
Cureus
Aburamadan A, Syed NS, Mohamed A, Otu A, Bond S +2 more
Plain English This study examined a rare case of a Nigerian woman living in the UK who felt a moving sensation in her right eye. Doctors found a live parasite, Loa loa, under the surface of her eye and had to surgically remove it. This case is important because it shows the need for awareness of tropical infections, even in places where they are not common, especially for pregnant women.
Who this helps: This helps doctors and healthcare providers better recognize and treat unusual infections.
Immunogenicity Assessment for siRNA Therapeutics: A Risk-Based Proposal for Event-Driven Testing.
2026
The AAPS journal
Zhao A, Bond S, Clausen V, Chen M, Lai CH +3 more
Plain English This study looked at the safety of a type of treatment called siRNA therapeutics, which have been successful in treating various diseases with eight products already approved. Researchers found that these treatments have a low risk of triggering unwanted immune responses, with only about 6% of patients developing antibodies against the drugs, and this had no negative effects on how the treatments worked. This matters because it suggests that we may not need to continually test for immune responses during the drug development process for these therapies, allowing for more efficient testing and development.
Who this helps: Patients who may benefit from siRNA therapies and their doctors.
Analysis of Infection Types, Pathogens, Antimicrobial Treatment, and Clinical Outcomes Data in Hospitalised Patients: Comprehensive Online Database for Antimicrobial Resistance (CODAR) Retrospective Pilot Study.
2026
Journal of epidemiology and global health
Townsend A, Mohamed N, Kuraieva A, Kuper K, Passarelli A +20 more
Plain English This study looked at infections and treatment outcomes for hospitalized patients in hospitals from five countries. Out of over 8,000 patients analyzed, urinary tract infections were the most common, especially in women, and antibiotics like meropenem and amoxicillin-clavulanate were frequently used. The research found that patients with skin infections had a high survival rate of 94.4%, while those with blood infections had lower survival rates around 81.7%, pointing to the need for better infection management for certain pathogens.
Who this helps: This research benefits doctors and healthcare providers by offering insights to improve patient treatment and outcomes.
A novel placement method of a calibration-free pH capsule for continuous wireless measurement of intragastric pH in horses.
2025
Journal of veterinary internal medicine
Hodgson E, Thirouin M, Narayanan P, Romano TR, Wise J +1 more
Plain English Researchers developed a new method to measure stomach acidity (pH) in horses using a wireless capsule. They successfully placed the capsule in different parts of the stomach of 11 healthy horses and found that it stayed attached for an average of 27 hours in the upper stomach and about 10 hours in the lower stomach, without causing damage to the stomach lining. This method allows for continuous pH monitoring, which is important for better understanding and managing horse health.
Who this helps: This benefits veterinarians and horse owners by improving ways to monitor horse stomach health.
Adjustable wind selectivity in shearwaters implies knowledge of the foraging landscape.
2025
Current biology : CB
Harris SM, Bishop CM, Bond S, Fernandes PG, Guilford T +7 more
Plain English This study looked at how Manx shearwaters, a type of seabird, make decisions about where to forage while flying. Researchers tracked the movements of 218 shearwaters using GPS and found that they adjust their flight patterns based on wind conditions and their knowledge of where food is located. Specifically, the birds were less selective about which winds to use when flying back to their breeding colony or when heading towards familiar feeding spots, suggesting they balance the energy costs of flying with the benefits of reaching these areas efficiently.
Who this helps: This research benefits conservationists and wildlife biologists studying bird behavior and habitat use.
Molecular survey of canine parvovirus type 2: the emergence of subtype 2c in New Zealand.
2025
New Zealand veterinary journal
Dunowska M, Bain H, Bond S
Plain English This study looked at the types of canine parvovirus in New Zealand by analyzing samples from 40 infected dogs and 1 cat. Researchers found that 95% of the viruses were a newer subtype called CPV-2c, mostly affecting young dogs, with 75% of infected dogs being under 6 months old. It's important because understanding these viruses helps ensure vaccines remain effective and protect dogs from severe illness.
Who this helps: This benefits dog owners, veterinarians, and animal health professionals.
Surgical resection of diffuse pulmonary arteriovenous malformations (PAVMs).
2025
JTCVS open
Falk AR, Nitsche LJ, Bontrager CE, Bond S, Beslow LA +7 more
Plain English This study looked at the effectiveness of surgery for treating pulmonary arteriovenous malformations (PAVMs) in 18 patients over a 14-year period. The results showed that after surgery, patients' oxygen levels improved significantly from 90% to 97%, and all patients survived without major complications. This matters because it highlights that surgery can be a safe and successful option for patients with complex PAVMs, especially when other treatments haven’t worked.
Who this helps: Patients with diffuse pulmonary arteriovenous malformations and their healthcare providers.
Microglia in ALS: Insights into Mechanisms and Therapeutic Potential.
2025
Cells
Bond S, Saxena S, Sierra-Delgado JA
Plain English This study looks at a condition called amyotrophic lateral sclerosis (ALS), which causes muscle weakness and paralysis by damaging nerve cells. Researchers found that microglia, the immune cells in the brain, play a significant role in ALS by both causing inflammation that harms nerve cells and, under some conditions, protecting them. Understanding how to change the way microglia work could lead to new treatments that slow down the progression of ALS.
Who this helps: This helps patients with ALS and their doctors.
Protocol for a randomized controlled trial of the Mommy&Me study: A multi-modal approach to address social determinants of health and mental health among low-income Black perinatal populations.
2025
Contemporary clinical trials communications
Le HN, Andescavage N, Keller JM, Bassa MM, Danielson AL +6 more
Plain English This study focuses on improving mental health care for low-income Black women during and after pregnancy, as they face higher rates of stress, anxiety, and depression compared to others. The researchers are testing a combination of support systems including patient navigation, culturally tailored therapy, and peer support groups, comparing these with standard care. They will track participants' mental health and experiences over time, aiming to find effective ways to reduce racial disparities in maternal health.
Who this helps: This benefits low-income Black pregnant women and new mothers.
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials.
2025
The Lancet. Respiratory medicine
Amstutz A, Schandelmaier S, Ewald H, Speich B, Schwenke JM +38 more
Plain English This study looked at Janus kinase (JAK) inhibitors in adults hospitalized due to COVID-19 to see how well they worked compared to standard care. It found that 11.7% of patients taking JAK inhibitors died within 28 days, compared to 13.2% of those who did not take these drugs, suggesting that JAK inhibitors could reduce deaths in these patients by about 39 per 1,000. Additionally, patients who received JAK inhibitors needed less mechanical ventilation and left the hospital about a day sooner, with fewer serious side effects reported.
Who this helps: This research benefits hospitalized COVID-19 patients.
Development of the Australian Rheumatology Association Clinical Care Standard for the Diagnosis and Management of Rheumatoid Arthritis in Adults.
2025
The Journal of rheumatology
Sukkar MB, Ainley R, Barrett C, Bond S, Bradbury LA +29 more
Plain English The study focused on creating a quality standard for diagnosing and managing rheumatoid arthritis (RA) in adults in Australia. Researchers developed 13 key statements about RA care through workshops and a national survey involving 605 consumers and 308 healthcare professionals, where 12 of these statements met the criteria for high priority and agreement. This standard aims to enhance the quality of care for adults with RA, ensuring they receive better treatment and support.
Who this helps: Patients with rheumatoid arthritis.
Phase I randomized double-blind study of an RNA interference therapeutic targeting HSD17B13 for metabolic dysfunction-associated steatohepatitis.
2025
Journal of hepatology
Sanyal AJ, Taubel J, Badri P, Bond S, Makarova N +5 more
Plain English This study focused on a new treatment called rapirosiran, which targets a gene linked to liver disease called HSD17B13. In a group of 46 adults with a liver condition known as metabolic dysfunction-associated steatohepatitis (MASH), rapirosiran reduced the activity of HSD17B13 by an impressive 78% after six months with minimal side effects. This finding is important because MASH is a common liver disease and current treatment options are very limited, making rapirosiran a promising potential therapy.
Who this helps: Patients with metabolic dysfunction-associated steatohepatitis (MASH).
Potent antioxidant and mitochondrial-protective effects of ATH434, a moderate affinity iron chaperone.
2025
The Journal of biological chemistry
Bailey DK, Nihlawi R, Bradbury MJ, Bond S, Kosman DJ
Plain English This study examined a new drug called ATH434, which aims to help patients with neurological diseases like Parkinson’s and Multiple System Atrophy (MSA) that are linked to excess iron in the brain. Researchers found that ATH434 effectively reduces brain iron and helps protect brain cells from damage caused by oxidation, with a notable improvement in motor function in animal models. This matters because it could lead to a new treatment option that not only targets iron build-up but also offers antioxidant protection to neurons.
Who this helps: This helps patients with Parkinson's disease and Multiple System Atrophy.
Corrigendum to Surgical resection of diffuse pulmonary arteriovenous malformations (PAVMs) [JTCVS Open Volume 23, February 2025, Pages 309-317].
2025
JTCVS open
Falk AR, Nitsche LJ, Bontrager CE, Bond S, Beslow LA +7 more
Plain English This paper corrects previous findings about the surgical removal of diffuse pulmonary arteriovenous malformations (PAVMs), which are abnormal connections between blood vessels in the lungs. The correction clarifies important details related to patient outcomes and results from surgical procedures, ensuring accurate information is available for future studies. This is important because clear data helps doctors make better decisions about treating patients with PAVMs effectively.
Who this helps: Patients with pulmonary arteriovenous malformations and their doctors.
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial.
2025
Journal of Crohn's & colitis
Noor NM, Davies N, Tahir W, Bond S, Dowling F +8 more
Plain English This study looked at two different treatment approaches for patients with active Crohn's disease: starting treatment aggressively (called "top-down") versus gradually increasing treatment as needed (called "step-up"). It found that the "top-down" approach not only led to better health outcomes, giving patients an average of 0.17 extra years of quality life, but it also cost less, saving about £1,681 per patient over five years. This research is important because it shows that patients can achieve better health with less expense when treated with the "top-down" method from the start.
Who this helps: Patients with active Crohn's disease.
Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study.
2025
Health technology assessment (Winchester, England)
Euden J, Albur M, Bestwick R, Bond S, Brookes-Howell L +33 more
Plain English This study looked at how testing for procalcitonin, a protein that can indicate bacterial infections, affected the use of antibiotics in COVID-19 patients in England and Wales. Researchers found that using procalcitonin testing led to a 0.43-day reduction in early antibiotic use and a total reduction of 0.72 days in antibiotic prescriptions, without increasing the risk of death or hospital stays. This is important because it shows that procalcitonin testing can help reduce unnecessary antibiotic use, which is crucial in fighting antibiotic resistance.
Who this helps: This helps patients with COVID-19 by reducing their exposure to unnecessary antibiotics.
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA (- Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA)- Regulatory Agencies' Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation).
2025
Bioanalysis
Bivi N, Graham D, Joglekar L, McGuire K, Stoop J +59 more
Plain English The 2024 workshop focused on key issues in bioanalysis, bringing together over 1,100 experts from pharma, biotech, and regulatory agencies to discuss topics like biomarker testing and new therapies. They made recommendations to improve the quality and compliance of various tests, particularly for gene therapies and vaccines, with an emphasis on how to implement new regulations in the U.S. and EU. This is important because it helps ensure that new medical tests and treatments are both effective and safe for patients.
Who this helps: This benefits patients and healthcare providers who rely on accurate testing and therapies.
Epidemiology and Healthcare Resource Utilization of Rett Syndrome in Canada: The Ontario Experience.
2025
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Bond S, Murray J, Datta AN, Rafay MF, McAdam L +3 more
Plain English This study examined Rett Syndrome (RTT) in Ontario, Canada, focusing on how many people are affected and how often they use healthcare services. Researchers found 246 cases of RTT, predominantly affecting females, with a median age of 21. Over a five-year period, nearly all patients had multiple healthcare visits, including 96.7% requiring outpatient care and 54.5% needing hospitalization, indicating a significant healthcare impact linked to conditions like epilepsy and developmental disabilities.
Who this helps: This helps patients with Rett Syndrome and their healthcare providers by highlighting the need for more targeted care and support.
2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A - Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV)).
2025
Bioanalysis
Hersey S, McGuire K, Kholmanskikh O, Bivi N, Bandukwala A +72 more
Plain English This paper summarizes discussions from a recent workshop where over 1,200 bioanalysis professionals gathered to focus on current issues related to measuring biomarkers and validating tests for new therapies and vaccines. The attendees made a series of recommendations aimed at improving testing quality and compliance with regulations to ensure better health outcomes. The importance of this work lies in its potential to enhance the reliability of new diagnostic tests and treatments, benefitting the overall healthcare system.
Who this helps: Patients and healthcare providers benefit from these improved diagnostic tools and therapies.
Characterization of medical device constituents and development of duration-based non-cancer threshold of toxicological concern values.
2025
Frontiers in toxicology
Builee T, Kennedy TA, Levelut V, Hahn MA, Bond S +8 more
Plain English This study looked at medical devices to create safe exposure limits for their chemical components, especially when there isn't detailed toxicity data available. Researchers analyzed over 15,000 substances, identifying 790 that could be safely evaluated, and established specific daily exposure limits: 112 micrograms per kilogram for short-term use, 111 micrograms for medium-term use, and 41 micrograms for long-term use. These findings help ensure that medical devices are safe for patients by providing clear guidelines on allowable chemical exposure.
Who this helps: Patients using medical devices.
A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH trial).
2024
Health technology assessment (Winchester, England)
Hutchinson PJ, Edlmann E, Hanrahan JG, Bulters D, Zolnourian A +31 more
Plain English This study looked at whether a two-week course of dexamethasone, a type of steroid, helps older adults with chronic subdural hematomas, which are collections of old blood in the brain. Out of 748 patients, those who received dexamethasone had a 6.4% lower rate of favorable outcomes 6 months later compared to those who received a placebo, and they also experienced more serious side effects (16% vs. 6.4%). The results suggest that dexamethasone is not effective or safe for treating this condition, and it is not a cost-effective option.
Who this helps: This helps doctors and healthcare providers understand that dexamethasone is not recommended for treating chronic subdural hematomas in older patients.
Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates.
2024
Nucleic acids research
Yu M, Qin J, Liu X, Ramsden D, Williams B +24 more
Plain English This study looked at how well a new type of medication called GalNAc-conjugated siRNAs could be delivered by mouth in animals, specifically rodents and non-human primates. They found that even though the oral administration wasn't very effective—only about 2% of the medicine reached the liver—it still worked better than expected when combined with special substances that help it absorb through the intestines. This research matters because finding effective oral delivery methods for these siRNAs could make treatments easier for patients who currently have to get them through injections.
Who this helps: Patients needing treatments for genetic diseases or conditions that require RNA-based therapies.
The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study.
2024
The Journal of antimicrobial chemotherapy
Webb EJD, Howdon D, Bestwick R, King N, Sandoe JAT +23 more
Plain English This study looked at whether testing for procalcitonin (PCT) in COVID-19 patients is a good way to decide when to use antibiotics and if it's cost-effective. Researchers found that patients who had PCT tests spent less time in the hospital and on antibiotics, leading to a slightly better quality of life (8.76 QALYs compared to 8.62) and lower costs (£9,830 vs £10,700). This matters because using PCT testing can help hospitals save money while also improving patient care during COVID-19 treatment.
Who this helps: This helps patients and healthcare providers by ensuring better treatment decisions and potentially lower costs.
International guideline comparison of lifestyle management for acute coronary syndrome and type 2 diabetes mellitus: A rapid review.
2024
Health policy (Amsterdam, Netherlands)
Kemp BJ, Thompson DR, Coates V, Bond S, Ski CF +2 more
Plain English This research looked at how guidelines for managing acute coronary syndrome (ACS) and type 2 diabetes (T2DM) are similarly structured across several countries, including Australia, Canada, and the UK. The study found significant overlap in care approaches for diet, exercise, and mental health that could be combined to make treatment simpler and more effective for patients with both conditions. By merging these guidelines, healthcare systems can reduce duplicated services and improve patient care.
Who this helps: This benefits patients with both acute coronary syndrome and type 2 diabetes.
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas.
2024
BMJ open
McGovern DP, McClure ME, Coates M, Bond S, Martinez Del Pero M +7 more
Plain English This study is comparing two treatments for a condition called ANCA-associated vasculitis (AAV), specifically looking at obinutuzumab versus rituximab. Researchers will include 26 patients who either have newly diagnosed AAV or are experiencing a relapse. They will measure the effectiveness of these treatments by looking at changes in specific immune cells in the body over time; for example, they will check how well each drug reduces B cells in a particular area of the immune system over 26 weeks.
Who this helps: This research benefits patients with ANCA-associated vasculitis by potentially identifying a more effective treatment option.
Long-term surveillance study of rituximab originator treated patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA).
2024
Rheumatology advances in practice
Uchida L, Jones RB, Smith RM, Nodale M, Bond S +6 more
Plain English The study examined patients with certain types of vasculitis (granulomatosis with polyangiitis or microscopic polyangiitis) who were treated with either rituximab or other therapies between 2003 and 2017. Researchers found that about 54% of patients treated with rituximab experienced a serious adverse event (SAE), compared to 40% of those treated with other methods, and patients on rituximab had a shorter time before experiencing their first SAE. This matters because, while rituximab may help with disease management, it also carries a higher risk of complications, including serious infections.
Who this helps: This information is useful for patients and doctors making treatment decisions for vasculitis.
Phytoplasma vignae', assigning a species description to a long-known phytoplasma occurring in northern Australia.
2024
International journal of systematic and evolutionary microbiology
Rodrigues Jardim B, Tran-Nguyen LTT, Gambley C, Webster C, Kehoe M +3 more
Plain English Researchers studied a specific type of bacteria called phytoplasma that affects plants, particularly focusing on one known as 'ViLL' found in northern Australia. They found that this phytoplasma is distinct from other known species and proposed a new name for it: 'Phytoplasma vignae.' This is significant because it helps improve our understanding of plant diseases, which can lead to better management and prevention strategies for affected crops.
Who this helps: This benefits farmers and agricultural specialists who work to manage plant health.
ATH434, a promising iron-targeting compound for treating iron regulation disorders.
2024
Metallomics : integrated biometal science
Pall AE, Bond S, Bailey DK, Stoj CS, Deschamps I +5 more
Plain English This study looked at a new compound called ATH434 that targets excess iron in the body, which is a problem for patients with rare disorders like Friedreich's Ataxia, Parkinson's disease, and Multiple System Atrophy. Researchers found that ATH434 has a strong ability to bind to toxic forms of iron (Fe2+) without increasing harmful reactive oxygen levels, which is a significant improvement over existing treatments like deferiprone and deferasirox that actually made things worse. This finding is important because it suggests that ATH434 could provide a safer and more effective treatment option for patients suffering from these disorders.
Who this helps: This helps patients with Friedreich's Ataxia, Parkinson's disease, and Multiple System Atrophy.
Interceptive abilities in autism spectrum disorder: Comparing naturalistic and virtual visuomotor tasks.
2024
Autism research : official journal of the International Society for Autism Research
Park SW, Cardinaux A, Crozier D, Russo M, Bond S +3 more
Plain English This study examined how children with autism and those without it (neurotypical) catch balls in real life and in a virtual setting. It involved 31 neurotypical children and 23 autistic children aged 7 to 12. The results showed that autistic children caught fewer balls compared to their neurotypical peers, particularly in tasks that required predicting where the ball would go, highlighting that difficulties in making predictions may be a key issue in autism.
Who this helps: This research helps children with autism and their caregivers by providing insights into their motor skills challenges.
Behavioural responses of a trans-hemispheric migrant to climate oscillation.
2024
Proceedings. Biological sciences
Siddiqi-Davies K, Wynn J, Padget O, Lewin P, Gillies N +15 more
Plain English This study looked at how the Manx shearwater, a migratory bird, responds to climate changes over several years, particularly during El Niño events. Researchers found that during El Niño years, these birds migrated to higher latitudes and foraged less, which negatively impacted their breeding success by reducing the time spent feeding their chicks. This matters because it shows how climate variation can disrupt food availability and breeding success for migratory species.
Who this helps: This research helps conservationists and ecologists understand the impacts of climate change on migratory bird populations.
Night flight facilitates late breeding catch-up in a long-distance migratory seabird.
2024
Scientific reports
Siddiqi-Davies K, Wynn J, Padget O, Bond S, Danielsen J +10 more
Plain English This study looked at how the timing of breeding affects the migration habits of the Manx shearwater, a seabird that travels long distances. Researchers found that birds that breeding later flew more at night and had shorter migration times, while those that bred earlier faced longer migrations and made more stops. This understanding shows that the breeding schedule can influence migratory behavior, helping birds better access food during their winter travels.
Who this helps: This information benefits conservationists and wildlife managers working to protect seabirds and their habitats.
Plain English This paper showcases the best visual media work in life sciences and medicine from the past ten years in the BioImages competition. The selected winners demonstrate a wide range of impressive images and graphics, highlighting the creativity and quality in the field. In 2021, the judging process was updated to enhance evaluation criteria and award categories.
Who this helps: This helps researchers, medical professionals, and educators by providing inspiring examples of visual communication in science.